Many angiotensin-converting enzyme (ACE) inhibitors have been shown to reduce mortality after acute myocardial infarction (AMI), yet no study has investigated if this is a class effect. Discharge prescription data were analyzed for patients ≥65 years old hospitalized for AMI in Quebec between 1996 and 1998. Among those prescribed an ACE inhibitor (n = 6,287), the association between the specific drug prescribed and mortality following AMI was studied using Cox proportional-hazards models. A propensity score analysis compared short-acting with long-acting ACE inhibitors to account for confounding by indication. / After adjusting for potentially confounding variables, enalapril, fosinopril, and captopril appeared less effective than ramipril at reducing mortality---hazard ratios (and 95% CI): 1.38 (1.01 to 1.89), 1.47 (1.05 to 2.05), and 1.46 (1.05 to 2.03), respectively. Lisinopril appeared to be as effective as ramipril. Short-acting ACE inhibitors were associated with higher mortality than long-acting ACE inhibitors, but only in certain subgroups. / Among patients prescribed an ACE inhibitor following AMI, it appears that the mortality benefits differ according to the specific drug prescribed.
Identifer | oai:union.ndltd.org:LACETR/oai:collectionscanada.gc.ca:QMM.33832 |
Date | January 2002 |
Creators | Rodrigues, Eric John. |
Contributors | Pilote, Louise (advisor), Paradis, Gilles (advisor) |
Publisher | McGill University |
Source Sets | Library and Archives Canada ETDs Repository / Centre d'archives des thèses électroniques de Bibliothèque et Archives Canada |
Language | English |
Detected Language | English |
Type | Electronic Thesis or Dissertation |
Format | application/pdf |
Coverage | Master of Science (Department of Epidemiology and Biostatistics.) |
Rights | All items in eScholarship@McGill are protected by copyright with all rights reserved unless otherwise indicated. |
Relation | alephsysno: 001863624, proquestno: MQ78949, Theses scanned by UMI/ProQuest. |
Page generated in 0.0018 seconds